Go back

Industry calls for more public funding to tackle drug resistance

Image: M J Richardson [CC BY-SA 2.0], via Geograph

More than 80 international drug and biotech firms have urged governments to commit more funding for research to combat drug-resistant infections.

In a declaration signed at the World Economic Forum in Davos on 21 January, 85 companies from 18 countries called for a more coordinated effort from governments to cut unnecessary use of antibiotics and support development of new ones.

The Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance, whose signatories include GlaxoSmithKline, AstraZeneca, Pfizer and Novartis, said that this should include changing drug prices as well as investing more in research.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.